RE-PERG作为原发性开角型青光眼的神经增强诊断工具:一项初步研究

Journal of Ophthalmology & Clinical Research Pub Date : 2022-12-22 DOI:10.24966/ocr-8887/100106

Alberto Mavilio

{"title":"RE-PERG作为原发性开角型青光眼的神经增强诊断工具:一项初步研究","authors":"Alberto Mavilio","doi":"10.24966/ocr-8887/100106","DOIUrl":null,"url":null,"abstract":"RE-PERG can detect variations in the metabolic status of the RGCs in glaucomatous patients after oral intake of a fixed combination of C+H in addition to topical treatment. RE-PERG can be a valid tool in neuroenhancement studies, representing a biological marker of neuronal performance","PeriodicalId":135031,"journal":{"name":"Journal of Ophthalmology & Clinical Research","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RE-PERG as a Diagnostic Tool for Neuroenhancement Studies in Primary Open Angle Glaucoma: A Pilot Study\",\"authors\":\"Alberto Mavilio\",\"doi\":\"10.24966/ocr-8887/100106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"RE-PERG can detect variations in the metabolic status of the RGCs in glaucomatous patients after oral intake of a fixed combination of C+H in addition to topical treatment. RE-PERG can be a valid tool in neuroenhancement studies, representing a biological marker of neuronal performance\",\"PeriodicalId\":135031,\"journal\":{\"name\":\"Journal of Ophthalmology & Clinical Research\",\"volume\":\"5 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Ophthalmology & Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24966/ocr-8887/100106\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology & Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24966/ocr-8887/100106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

RE-PERG可以检测青光眼患者口服C+H固定组合治疗后rgc代谢状态的变化。RE-PERG可以作为神经增强研究的有效工具，代表神经元性能的生物学标记

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

RE-PERG as a Diagnostic Tool for Neuroenhancement Studies in Primary Open Angle Glaucoma: A Pilot Study

RE-PERG can detect variations in the metabolic status of the RGCs in glaucomatous patients after oral intake of a fixed combination of C+H in addition to topical treatment. RE-PERG can be a valid tool in neuroenhancement studies, representing a biological marker of neuronal performance

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Ophthalmology & Clinical Research

自引率

0.00%

发文量